A shadow market for unapproved slimming medications is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Drug Gaining Popularity Online
The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to contact these profiles directly for source information, while also obtaining promotional offers.
Thriving Trade on Social Networks
Additionally, a robust trade exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and claims of rapid British shipping. Vendors market the substance there before directing customers to other platforms for purchases.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.
Healthcare Professionals Express Concerns
Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could result in individuals administering substances of uncertain source.
Several experts said the popularity for the experimental drug could be connected to the increasing price of licensed weight loss treatments such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and customer laws, potentially leading to fines, legal action or imprisonment.
Service Reaction and Material Elimination
According to TikTok, the service has removed violative content and banned associated hashtags and search suggestions. The company stated it was committed to keeping the platform safe and investing in enhancing compliance measures.
Online Trading Activities
Investigations also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly displays groups with thousands of users, filled with images of slimming results, glowing testimonials and detailed instructions for preparing or injecting at home.
After moments of entering one community, a seller posted contact information, where most transactions take place. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, health issues or previous experience.
Product Details and Pricing
Within these groups, posts display black plastic parcels with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When questioned how long a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Measures
A representative for the messaging service said it actively moderated harmful material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her staff has previously encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet authorized … may subject patients to potentially serious medical dangers”.
